These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38507274)

  • 1. Correction to "Efficacy and safety of curcumin in major depressive disorder: A randomized controlled trial".
    Phytother Res; 2024 May; 38(5):2594. PubMed ID: 38507274
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial.
    Sanmukhani J; Satodia V; Trivedi J; Patel T; Tiwari D; Panchal B; Goel A; Tripathi CB
    Phytother Res; 2014 Apr; 28(4):579-85. PubMed ID: 23832433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: A randomised, double-blind, placebo-controlled study.
    Lopresti AL; Drummond PD
    J Affect Disord; 2017 Jan; 207():188-196. PubMed ID: 27723543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.
    Yu JJ; Pei LB; Zhang Y; Wen ZY; Yang JL
    J Clin Psychopharmacol; 2015 Aug; 35(4):406-10. PubMed ID: 26066335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study.
    Lopresti AL; Maes M; Maker GL; Hood SD; Drummond PD
    J Affect Disord; 2014; 167():368-75. PubMed ID: 25046624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin and major depression: a randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change.
    Lopresti AL; Maes M; Meddens MJ; Maker GL; Arnoldussen E; Drummond PD
    Eur Neuropsychopharmacol; 2015 Jan; 25(1):38-50. PubMed ID: 25523883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Gyejibokryeong-hwan (GBH) in major depressive disorder: study protocol for multicentre randomised controlled trial.
    Choi Y; Jung IC; Kim JY; Cho SH; Kim Y; Chung SY; Kwak HY; Lee DS; Lee W; Nam IJ; Yang C; Lee MY
    Trials; 2022 Jun; 23(1):447. PubMed ID: 35650612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.
    Liu H; Lan X; Wang C; Zhang F; Fu L; Li W; Ye Y; Hu Z; Chao Z; Ning Y; Zhou Y
    BMC Psychiatry; 2022 Nov; 22(1):744. PubMed ID: 36451150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial.
    Saghatelyan T; Tananyan A; Janoyan N; Tadevosyan A; Petrosyan H; Hovhannisyan A; Hayrapetyan L; Arustamyan M; Arnhold J; Rotmann AR; Hovhannisyan A; Panossian A
    Phytomedicine; 2020 Apr; 70():153218. PubMed ID: 32335356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Curcumin Administration in Patients with Major Depressive Disorder: Mini Meta-Analysis of Clinical Trials.
    Al-Karawi D; Al Mamoori DA; Tayyar Y
    Phytother Res; 2016 Feb; 30(2):175-83. PubMed ID: 26610378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder.
    Shiovitz T; Greenberg WM; Chen C; Forero G; Gommoll CP
    Innov Clin Neurosci; 2014 Jan; 11(1-2):10-22. PubMed ID: 24653937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 6-week, multicentre, randomized controlled clinical trial to evaluate the safety and efficacy of placeboxetine hydrochloride in the treatment of major depressive disorder in an Indian setting.
    Andrade C
    Indian J Psychiatry; 2011 Jan; 53(1):69-72. PubMed ID: 21431013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study.
    Kanchanatawan B; Tangwongchai S; Sughondhabhirom A; Suppapitiporn S; Hemrunrojn S; Carvalho AF; Maes M
    Neurotox Res; 2018 Apr; 33(3):621-633. PubMed ID: 29327213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Adding Curcumin to Sertraline in the Treatment of Severe Major Depressive Disorder: A Randomized, Double-Blind Clinical Trial.
    Talaei A; Noori R; Rezaei Ardani A; Mohammadpour AH; Azimipoor Z; Afzaljavan F
    Clin Neuropharmacol; 2023 Apr; ():. PubMed ID: 37071480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of Duloxetine in Children and Adolescents with Major Depressive Disorder in Japan: A Randomized Double-Blind Placebo-Controlled Clinical Trial Followed by an Open-Label Long-Term Extension Trial.
    Saito T; Ishida M; Nishiyori A; Ochiai T; Katagiri H; Matsumoto H
    J Child Adolesc Psychopharmacol; 2022 Apr; 32(3):132-142. PubMed ID: 35319270
    [No Abstract]   [Full Text] [Related]  

  • 16. Bangpungtongsung-san for patients with major depressive disorder: study protocol for a randomized controlled phase II clinical trial.
    Kim Y; Choi Y; Lee MY; Cho SH; Jung IC; Kang DH; Yang C
    BMC Complement Med Ther; 2023 Apr; 23(1):114. PubMed ID: 37046297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertraline Versus Placebo in Patients with Major Depressive Disorder Undergoing Hemodialysis: A Randomized, Controlled Feasibility Trial.
    Friedli K; Guirguis A; Almond M; Day C; Chilcot J; Da Silva-Gane M; Davenport A; Fineberg NA; Spencer B; Wellsted D; Farrington K
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):280-286. PubMed ID: 28126706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial.
    Huang J; Yu Y; Jiang Y; Chen W; Li Y; Shen Y; Zheng Q; Li H
    Trials; 2021 Sep; 22(1):585. PubMed ID: 34479619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin for maintenance of remission in ulcerative colitis.
    Kumar S; Ahuja V; Sankar MJ; Kumar A; Moss AC
    Cochrane Database Syst Rev; 2012 Oct; 10():CD008424. PubMed ID: 23076948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture plus moxibustion therapy for patients with major depressive disorder: study protocol for a randomized controlled trial.
    Kim M; Choi EJ; Kim SP; Kim JE; Park HJ; Kim AR; Seo BN; Kwon OJ; Cho JH; Chung SY; Kim JH
    Trials; 2017 Jan; 18(1):16. PubMed ID: 28086934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.